 staff unanimously voted to not give this company approval for their gene therapy. Well, she just overrode their approval and said no, or their disapproval. And she said, no, I'm going to approve it because if we don't approve it, then the company is not going to continue getting funding, and we're also not going to open up the gateway for innovative research in this disease state. And by the way, Pfizer started studying –